2018 Annual Meeting | C87 - Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II

Date Monday 04/23/18

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Jeffrey M. Gelfand, MD, MS, F�鶹��ýӳ��

Topic(s)

Learning Objectives Participants should become familiar with the differential diagnosis of neurological manifestations of systemic inflammatory, autoimmune, and rheumatological diseases; be able to identify common phenotypes associated with neurological organ system involvement of rheumatological syndromes; learn ways of distinguishing neuro-rheumatological diagnoses from other neuroinflammatory disorders; and develop practical approaches to treatment, care coordination, and health maintenance for neuro-rheumatological conditions.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Interactive

Event Timeline
03:30 PM - 04:10 PM	Speaker	CNS Vasculitis and Mimics Rula Hajj-Ali, MD
04:10 PM - 04:50 PM	Speaker	Neurosarcoidosis, Pachymeningitis, Behcet's Disease Jeffrey M. Gelfand, MD, MS, F�鶹��ýӳ��
04:50 PM - 05:30 PM	Speaker	Case Discussions with Faculty Neurologists and Rheumatologists; Questions and Answers

Faculty Disclosures
Jeffrey M. Gelfand, MD, MS, F�鶹��ýӳ��	Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to �鶹��ýӳ�� interests or activities.
Rula Hajj-Ali, MD	Rula Hajj-Ali, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Rula Hajj-Ali, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zena. Rula Hajj-Ali, MD has received publishing royalties from a publication relating to health care.